Last Updated: November 8, 2026

SANCTURA Drug Patent Profile

Name: SANCTURA Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

« Back to Dashboard

When do Sanctura patents expire, and what generic alternatives are available?

Sanctura is a drug marketed by Allergan and is included in two NDAs.

The generic ingredient in SANCTURA is trospium chloride. There is one drug master file entry for this compound. Twenty suppliers are listed for this compound. Additional details are available on the trospium chloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Sanctura

A generic version of SANCTURA was approved as trospium chloride by GLENMARK PHARMS LTD on August 13^th, 2010.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for SANCTURA?
What are the global sales for SANCTURA?
What is Average Wholesale Price for SANCTURA?

Summary for SANCTURA

US Patents:	0
Applicants:	1
NDAs:	2
Raw Ingredient (Bulk) Api Vendors:	57
Clinical Trials:	8
Patent Applications:	1,071
DailyMed Link:	SANCTURA at DailyMed

Drug patent expirations by year for SANCTURA

Recent Clinical Trials for SANCTURA

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Neil M. Resnick	Phase 4
National Institute on Aging (NIA)	Phase 4
Karuna Therapeutics	Phase 1

See all SANCTURA clinical trials

US Patents and Regulatory Information for SANCTURA

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Allergan	SANCTURA	trospium chloride	TABLET;ORAL	021595-001	May 28, 2004		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Allergan	SANCTURA XR	trospium chloride	CAPSULE, EXTENDED RELEASE;ORAL	022103-001	Aug 3, 2007		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.